Zinc Completed Phase 2 Trials for Systemic Lupus Erythematosus (SLE) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00076752Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus